ÂÜÀòÂÒÂ×

Ambaw Bellete is an accomplished executive in the life sciences industry, currently serving as President & Chief Operating Officer at CG Oncology since September 2023, focusing on oncolytic immunotherapy for urologic cancer. Bellete also contributes as a Board Member of The Axiom REACH Foundation, addressing public health disparities, and serves as Chairman of OncoSTING. Membership in Mid Atlantic Bio Angels allows involvement as an investor in emerging life science companies. Previously, Bellete held the position of Chief Executive Officer at Lion Healthcare Strategies and was Chief Operating Officer at FerGene, both roles emphasizing strategic direction in biopharmaceuticals. As Chairman of the Public Policy Committee for BioNJ, Bellete played a pivotal role in advancing healthcare innovation in New Jersey. Other notable experiences include leadership roles at Photocure, MCS Inc., and Sanofi, where Bellete honed expertise in commercialization and product development across various therapeutic areas.